Epigenetic regulation of gastrointestinal cancers mediated by long non-coding RNAs

Long noncoding RNAs (lncRNAs), as well-known modulator of the epigenetic processes, have been shown to contribute to normal cellular physiological and pathological conditions such as cancer. Through the interaction with epigenetic regulators, an aberrant regulation of gene expression can be resulted...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer biomarkers : section A of Disease markers 2022-01, Vol.35 (4), p.359-377
Hauptverfasser: Akbari, Abolfazl, Abbasi, Somayeh, Borumandnia, Nasrin, Eshkiki, Zahra Shokati, Sedaghat, Meghdad, Tabaeian, Seidamir Pasha, Kashani, Amirhossein Faghihi, Talebi, Atefeh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 377
container_issue 4
container_start_page 359
container_title Cancer biomarkers : section A of Disease markers
container_volume 35
creator Akbari, Abolfazl
Abbasi, Somayeh
Borumandnia, Nasrin
Eshkiki, Zahra Shokati
Sedaghat, Meghdad
Tabaeian, Seidamir Pasha
Kashani, Amirhossein Faghihi
Talebi, Atefeh
description Long noncoding RNAs (lncRNAs), as well-known modulator of the epigenetic processes, have been shown to contribute to normal cellular physiological and pathological conditions such as cancer. Through the interaction with epigenetic regulators, an aberrant regulation of gene expression can be resulted due to their dysregulation, which in turn, can be involved in tumorigenesis. In the present study, we reviewed the lncRNAs’ function and mechanisms that contributed to aberrant epigenetic regulation, which is directly related to gastrointestinal cancer (GI) development and progression. Findings indicated that epigenetic alterations may involve in tumorigenesis and are valuable biomarkers in case of diagnosing, assessing of risk factors, and predicting of GI cancers. This review summarized the accumulated evidence for biological and clinical application to use lncRNAs in GI cancers, including colorectal, gastric, oral, liver, pancreatic and oesophageal cancer.
doi_str_mv 10.3233/CBM-220142
format Article
fullrecord <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_miscellaneous_2738491354</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.3233_CBM-220142</sage_id><sourcerecordid>2755930978</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-b8a881dba98e1fb992472d23f7f9e85b636e4b50c4729bbf2688f117017f59693</originalsourceid><addsrcrecordid>eNptkEtLxDAQx4Morq-LH0AKHhShmmebHNfFF6wKoueSpEnJ0k3WpD347c2yPkA8zTD8-M_MD4BjBC8JJuRqdv1YYgwRxVtgD_GalZwJvJ17VtMSIkYmYD-lBYSUICx2wYRUFFJGqj3wcrNynfFmcLqIpht7Objgi2CLTqYhBucHkwbnZV9o6bWJqVia1snBtIX6KPrgu8IHX-rQuty-PE3TIdixsk_m6KsegLfbm9fZfTl_vnuYTeelpogMpeKSc9QqKbhBVgmBaY1bTGxtheFMVaQyVDGo81goZXHFuUWohqi2TFSCHIDzTe4qhvcxX9ksXdKm76U3YUwNrgmnAhFGM3r6B12EMean1hRjgkBR80xdbCgdQ0rR2GYV3VLGjwbBZm26yaabjekMn3xFjiob-UG_1WbgbAMk2Znfff9EfQLOj4M9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2755930978</pqid></control><display><type>article</type><title>Epigenetic regulation of gastrointestinal cancers mediated by long non-coding RNAs</title><source>Sage Journals GOLD Open Access 2024</source><creator>Akbari, Abolfazl ; Abbasi, Somayeh ; Borumandnia, Nasrin ; Eshkiki, Zahra Shokati ; Sedaghat, Meghdad ; Tabaeian, Seidamir Pasha ; Kashani, Amirhossein Faghihi ; Talebi, Atefeh</creator><creatorcontrib>Akbari, Abolfazl ; Abbasi, Somayeh ; Borumandnia, Nasrin ; Eshkiki, Zahra Shokati ; Sedaghat, Meghdad ; Tabaeian, Seidamir Pasha ; Kashani, Amirhossein Faghihi ; Talebi, Atefeh</creatorcontrib><description>Long noncoding RNAs (lncRNAs), as well-known modulator of the epigenetic processes, have been shown to contribute to normal cellular physiological and pathological conditions such as cancer. Through the interaction with epigenetic regulators, an aberrant regulation of gene expression can be resulted due to their dysregulation, which in turn, can be involved in tumorigenesis. In the present study, we reviewed the lncRNAs’ function and mechanisms that contributed to aberrant epigenetic regulation, which is directly related to gastrointestinal cancer (GI) development and progression. Findings indicated that epigenetic alterations may involve in tumorigenesis and are valuable biomarkers in case of diagnosing, assessing of risk factors, and predicting of GI cancers. This review summarized the accumulated evidence for biological and clinical application to use lncRNAs in GI cancers, including colorectal, gastric, oral, liver, pancreatic and oesophageal cancer.</description><identifier>ISSN: 1574-0153</identifier><identifier>EISSN: 1875-8592</identifier><identifier>DOI: 10.3233/CBM-220142</identifier><identifier>PMID: 36404536</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Bioaccumulation ; Biomarkers ; Cancer ; Carcinogenesis - genetics ; Epigenesis, Genetic ; Epigenetics ; Esophageal cancer ; Gastrointestinal cancer ; Gastrointestinal Neoplasms - genetics ; Gene expression ; Gene Expression Regulation, Neoplastic ; Humans ; Liver cancer ; Non-coding RNA ; Pancreatic cancer ; Risk analysis ; Risk factors ; RNA, Long Noncoding - genetics ; RNA, Long Noncoding - metabolism ; Tumorigenesis</subject><ispartof>Cancer biomarkers : section A of Disease markers, 2022-01, Vol.35 (4), p.359-377</ispartof><rights>2022 – IOS Press. All rights reserved.</rights><rights>Copyright IOS Press BV 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-b8a881dba98e1fb992472d23f7f9e85b636e4b50c4729bbf2688f117017f59693</citedby><cites>FETCH-LOGICAL-c413t-b8a881dba98e1fb992472d23f7f9e85b636e4b50c4729bbf2688f117017f59693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.3233/CBM-220142$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.3233/CBM-220142$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21945,27830,27901,27902,44921,45309</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.3233/CBM-220142?utm_source=summon&amp;utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36404536$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Akbari, Abolfazl</creatorcontrib><creatorcontrib>Abbasi, Somayeh</creatorcontrib><creatorcontrib>Borumandnia, Nasrin</creatorcontrib><creatorcontrib>Eshkiki, Zahra Shokati</creatorcontrib><creatorcontrib>Sedaghat, Meghdad</creatorcontrib><creatorcontrib>Tabaeian, Seidamir Pasha</creatorcontrib><creatorcontrib>Kashani, Amirhossein Faghihi</creatorcontrib><creatorcontrib>Talebi, Atefeh</creatorcontrib><title>Epigenetic regulation of gastrointestinal cancers mediated by long non-coding RNAs</title><title>Cancer biomarkers : section A of Disease markers</title><addtitle>Cancer Biomark</addtitle><description>Long noncoding RNAs (lncRNAs), as well-known modulator of the epigenetic processes, have been shown to contribute to normal cellular physiological and pathological conditions such as cancer. Through the interaction with epigenetic regulators, an aberrant regulation of gene expression can be resulted due to their dysregulation, which in turn, can be involved in tumorigenesis. In the present study, we reviewed the lncRNAs’ function and mechanisms that contributed to aberrant epigenetic regulation, which is directly related to gastrointestinal cancer (GI) development and progression. Findings indicated that epigenetic alterations may involve in tumorigenesis and are valuable biomarkers in case of diagnosing, assessing of risk factors, and predicting of GI cancers. This review summarized the accumulated evidence for biological and clinical application to use lncRNAs in GI cancers, including colorectal, gastric, oral, liver, pancreatic and oesophageal cancer.</description><subject>Bioaccumulation</subject><subject>Biomarkers</subject><subject>Cancer</subject><subject>Carcinogenesis - genetics</subject><subject>Epigenesis, Genetic</subject><subject>Epigenetics</subject><subject>Esophageal cancer</subject><subject>Gastrointestinal cancer</subject><subject>Gastrointestinal Neoplasms - genetics</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Liver cancer</subject><subject>Non-coding RNA</subject><subject>Pancreatic cancer</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>RNA, Long Noncoding - genetics</subject><subject>RNA, Long Noncoding - metabolism</subject><subject>Tumorigenesis</subject><issn>1574-0153</issn><issn>1875-8592</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkEtLxDAQx4Morq-LH0AKHhShmmebHNfFF6wKoueSpEnJ0k3WpD347c2yPkA8zTD8-M_MD4BjBC8JJuRqdv1YYgwRxVtgD_GalZwJvJ17VtMSIkYmYD-lBYSUICx2wYRUFFJGqj3wcrNynfFmcLqIpht7Objgi2CLTqYhBucHkwbnZV9o6bWJqVia1snBtIX6KPrgu8IHX-rQuty-PE3TIdixsk_m6KsegLfbm9fZfTl_vnuYTeelpogMpeKSc9QqKbhBVgmBaY1bTGxtheFMVaQyVDGo81goZXHFuUWohqi2TFSCHIDzTe4qhvcxX9ksXdKm76U3YUwNrgmnAhFGM3r6B12EMean1hRjgkBR80xdbCgdQ0rR2GYV3VLGjwbBZm26yaabjekMn3xFjiob-UG_1WbgbAMk2Znfff9EfQLOj4M9</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Akbari, Abolfazl</creator><creator>Abbasi, Somayeh</creator><creator>Borumandnia, Nasrin</creator><creator>Eshkiki, Zahra Shokati</creator><creator>Sedaghat, Meghdad</creator><creator>Tabaeian, Seidamir Pasha</creator><creator>Kashani, Amirhossein Faghihi</creator><creator>Talebi, Atefeh</creator><general>SAGE Publications</general><general>IOS Press BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20220101</creationdate><title>Epigenetic regulation of gastrointestinal cancers mediated by long non-coding RNAs</title><author>Akbari, Abolfazl ; Abbasi, Somayeh ; Borumandnia, Nasrin ; Eshkiki, Zahra Shokati ; Sedaghat, Meghdad ; Tabaeian, Seidamir Pasha ; Kashani, Amirhossein Faghihi ; Talebi, Atefeh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-b8a881dba98e1fb992472d23f7f9e85b636e4b50c4729bbf2688f117017f59693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Bioaccumulation</topic><topic>Biomarkers</topic><topic>Cancer</topic><topic>Carcinogenesis - genetics</topic><topic>Epigenesis, Genetic</topic><topic>Epigenetics</topic><topic>Esophageal cancer</topic><topic>Gastrointestinal cancer</topic><topic>Gastrointestinal Neoplasms - genetics</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Liver cancer</topic><topic>Non-coding RNA</topic><topic>Pancreatic cancer</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>RNA, Long Noncoding - genetics</topic><topic>RNA, Long Noncoding - metabolism</topic><topic>Tumorigenesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akbari, Abolfazl</creatorcontrib><creatorcontrib>Abbasi, Somayeh</creatorcontrib><creatorcontrib>Borumandnia, Nasrin</creatorcontrib><creatorcontrib>Eshkiki, Zahra Shokati</creatorcontrib><creatorcontrib>Sedaghat, Meghdad</creatorcontrib><creatorcontrib>Tabaeian, Seidamir Pasha</creatorcontrib><creatorcontrib>Kashani, Amirhossein Faghihi</creatorcontrib><creatorcontrib>Talebi, Atefeh</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer biomarkers : section A of Disease markers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Akbari, Abolfazl</au><au>Abbasi, Somayeh</au><au>Borumandnia, Nasrin</au><au>Eshkiki, Zahra Shokati</au><au>Sedaghat, Meghdad</au><au>Tabaeian, Seidamir Pasha</au><au>Kashani, Amirhossein Faghihi</au><au>Talebi, Atefeh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epigenetic regulation of gastrointestinal cancers mediated by long non-coding RNAs</atitle><jtitle>Cancer biomarkers : section A of Disease markers</jtitle><addtitle>Cancer Biomark</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>35</volume><issue>4</issue><spage>359</spage><epage>377</epage><pages>359-377</pages><issn>1574-0153</issn><eissn>1875-8592</eissn><abstract>Long noncoding RNAs (lncRNAs), as well-known modulator of the epigenetic processes, have been shown to contribute to normal cellular physiological and pathological conditions such as cancer. Through the interaction with epigenetic regulators, an aberrant regulation of gene expression can be resulted due to their dysregulation, which in turn, can be involved in tumorigenesis. In the present study, we reviewed the lncRNAs’ function and mechanisms that contributed to aberrant epigenetic regulation, which is directly related to gastrointestinal cancer (GI) development and progression. Findings indicated that epigenetic alterations may involve in tumorigenesis and are valuable biomarkers in case of diagnosing, assessing of risk factors, and predicting of GI cancers. This review summarized the accumulated evidence for biological and clinical application to use lncRNAs in GI cancers, including colorectal, gastric, oral, liver, pancreatic and oesophageal cancer.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>36404536</pmid><doi>10.3233/CBM-220142</doi><tpages>19</tpages></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 1574-0153
ispartof Cancer biomarkers : section A of Disease markers, 2022-01, Vol.35 (4), p.359-377
issn 1574-0153
1875-8592
language eng
recordid cdi_proquest_miscellaneous_2738491354
source Sage Journals GOLD Open Access 2024
subjects Bioaccumulation
Biomarkers
Cancer
Carcinogenesis - genetics
Epigenesis, Genetic
Epigenetics
Esophageal cancer
Gastrointestinal cancer
Gastrointestinal Neoplasms - genetics
Gene expression
Gene Expression Regulation, Neoplastic
Humans
Liver cancer
Non-coding RNA
Pancreatic cancer
Risk analysis
Risk factors
RNA, Long Noncoding - genetics
RNA, Long Noncoding - metabolism
Tumorigenesis
title Epigenetic regulation of gastrointestinal cancers mediated by long non-coding RNAs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T15%3A44%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epigenetic%20regulation%20of%20gastrointestinal%20cancers%20mediated%20by%20long%20non-coding%20RNAs&rft.jtitle=Cancer%20biomarkers%20:%20section%20A%20of%20Disease%20markers&rft.au=Akbari,%20Abolfazl&rft.date=2022-01-01&rft.volume=35&rft.issue=4&rft.spage=359&rft.epage=377&rft.pages=359-377&rft.issn=1574-0153&rft.eissn=1875-8592&rft_id=info:doi/10.3233/CBM-220142&rft_dat=%3Cproquest_AFRWT%3E2755930978%3C/proquest_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2755930978&rft_id=info:pmid/36404536&rft_sage_id=10.3233_CBM-220142&rfr_iscdi=true